icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016
Back grey_arrow_rt.gif
 
 
 
Safety and Tolerability of Direct Acting Antiviral Agents (DAAs)
Used in Usual Clinical Practice: HCV-TARGET International Consortium

 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA
 
Michael W. Fried, K. Rajender Reddy, Mitchell L. Shiffman, Stefan Zeuzem, Norah Terrault, Alexander Kuo, Paul J. Pockros, Mark S. Sulkowski, Michael P. Manns, Jacqueline G. O'Leary, Lucy Akushevich, Monika Vainorius, David R. Nelson, Joseph K. Lim

HIV1

HIV2

HIV3

HIV4

HIV5

HIV6

HIV7

HIV8

HIV9

HIV10